ATE172204T1 - Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität - Google Patents

Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität

Info

Publication number
ATE172204T1
ATE172204T1 AT93913276T AT93913276T ATE172204T1 AT E172204 T1 ATE172204 T1 AT E172204T1 AT 93913276 T AT93913276 T AT 93913276T AT 93913276 T AT93913276 T AT 93913276T AT E172204 T1 ATE172204 T1 AT E172204T1
Authority
AT
Austria
Prior art keywords
pct
alpha
double stranded
peptide compounds
sec
Prior art date
Application number
AT93913276T
Other languages
English (en)
Inventor
Kjell Undheim
Peter Kremminger
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211675A external-priority patent/GB9211675D0/en
Priority claimed from GB929211674A external-priority patent/GB9211674D0/en
Priority claimed from GB929211676A external-priority patent/GB9211676D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Application granted granted Critical
Publication of ATE172204T1 publication Critical patent/ATE172204T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93913276T 1992-06-02 1993-06-02 Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität ATE172204T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929211675A GB9211675D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211674A GB9211674D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211676A GB9211676D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (1)

Publication Number Publication Date
ATE172204T1 true ATE172204T1 (de) 1998-10-15

Family

ID=27266223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913276T ATE172204T1 (de) 1992-06-02 1993-06-02 Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität

Country Status (11)

Country Link
US (1) US5610141A (de)
EP (1) EP0673388B1 (de)
JP (1) JPH08501066A (de)
CN (1) CN1086221A (de)
AT (1) ATE172204T1 (de)
AU (1) AU4340393A (de)
DE (1) DE69321605D1 (de)
EE (1) EE9400180A (de)
LV (1) LV10288B (de)
NO (1) NO944669L (de)
WO (1) WO1993024523A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
JP6150726B2 (ja) 2011-03-09 2017-06-21 Jitsubo株式会社 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN108059663A (zh) * 2018-02-10 2018-05-22 润辉生物技术（威海）有限公司 一种来考诺肽的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
EE9400180A (et) 1996-02-15
EP0673388A1 (de) 1995-09-27
WO1993024523A1 (en) 1993-12-09
NO944669D0 (no) 1994-12-02
NO944669L (no) 1994-12-02
DE69321605D1 (de) 1998-11-19
CN1086221A (zh) 1994-05-04
LV10288A (lv) 1994-10-20
LV10288B (en) 1995-04-20
AU4340393A (en) 1993-12-30
EP0673388B1 (de) 1998-10-14
JPH08501066A (ja) 1996-02-06
US5610141A (en) 1997-03-11

Similar Documents

Publication Publication Date Title
DK1288223T3 (da) Terapeutiske peptidderivater
DK0815245T3 (da) Bioaktive IL 12 fusionsproteiner
TR199700610A2 (xx) D���k molek�l a��rl�kl� ��z�n�r, t�m�r nekroz fakt�r� tip-I ve tip-II proteinleri.
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
ATE110742T1 (de) Peptid-verbindungen.
ATE172204T1 (de) Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität
NO944668L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties